Assessing Frailty and Its Impacts in Older Patients Facing Major Gastrointestinal Surgery

What this Trial Is About

This research aims to evaluate three new tests designed to measure frailty more easily in patients awaiting surgery for bowel cancer. Frailty is common in older patients, especially those over 75, and is linked to higher risks of complications and death after surgery. The study seeks to improve how frailty is identified before surgery to support better counseling and potential treatments that could enhance patient fitness and safety. All participants will complete baseline assessments including functional, frailty, nutritional, and quality of life questionnaires, along with a blood test. A subgroup of 30 participants, split evenly between frail and non-frail patients, will wear a digital motion device for seven days before surgery. Assessments are scheduled to coincide with routine clinic visits, and participants opting for the device will receive instructions on its use. Participants will be involved in various evaluations such as blood tests, questionnaires, and the use of a digital motion device for some. Researchers will monitor frailty levels, mortality, adverse events, and quality of life after surgery at specific intervals. The study will also track survival rates at 3 months and 5 years. The total participation timeline extends until December 2029, with ongoing data collection to better understand frailtys impact on surgical outcomes.

Assessing Frailty and Its Impacts on Patients Facing Major GI Surgery